MAY 02, 2022 3:00 AM PDT

Prostate Cancer: What's in a Name?

WRITTEN BY: Katie Kokolus

Hearing the word “cancer” could have a significant psychological impact on a patient waiting on a diagnosis.  In fact, the “c-word” has emerged as a colloquial expression due, at least in part, to an unconscious effort to avoid mention of the mere word: cancer.  The NCI notes that cancer patients can experience a wide range of new emotions and feelings following a diagnosis, and patients may feel anger, fear, sadness, depression, guilt, or loneliness.  While many experience such negative emotions, others may feel hope or gratitude, even thinking of their diagnosis as a wake-up call to promote a lifestyle change.  Notably, a cancer diagnosis can put a patient on an emotional roller coaster, regularly cycling through positive and negative feelings.

Mounting evidence suggests that emotional wellness can impact various avenues for cancer patients, including treatment participation and quality of life, which results in poorer outcomes and increased cancer deaths.  Given this, it makes sense that doctors consider the psychological weight of a cancer diagnosis and contemplate the impact of the “c-word” itself in some unique cases.  A manuscript recently published in the Journal of Clinical Oncology addresses this exact issue.  The authors argue doctors should stop using “cancer” for cases of very low-grade prostate cancer.  The article was penned by researchers from various universities and research institutes and a Patient-Advocate whose contribution ensured the commentary received a unique, non-medical perspective.

The Prostate-Specific Antigen (PSA) test greatly enhanced early detection of prostate cancer, cutting prostate cancer deaths in half.  However, accelerated early detection did not come without unintended consequences, mainly, many men diagnosed and treated for prostate cancer so indolent that it would have never impacted the life.  Specifically, almost 70% of diagnosed prostate cancers were low-grade cancers that likely did not require treatment.  In other words, these patients would not have died or even experienced any cancer-related symptoms had they not been treated. 

The authors suggest that “a major contributing factor to overdiagnosis and overtreatment is the designation of a particular pattern of low-grade cellular changes in the prostate as cancer, which, in our view, should not be called cancer.”  Despite their options, the authors acknowledge counterarguments towards dropping “cancer” when referring to these low-grade cases.  Notably, even men with low-grade prostate cancer benefit from active surveillance, which can develop into higher-grade malignancies requiring biopsies for detection.   Other experts worry that removing the cancer distinction could result in some patients not taking their condition seriously and appropriately monitoring disease progression. 

The indication that overdiagnosis and overtreatment of prostate cancer could have adverse effects led to many medical organizations cautioning against routine PSA testing.  Thus, PSA testing has become more nuanced and is recommended only for specific scenarios, including high-risk patients.  At this point, no broad guidance has been issued regarding using the “c-word” for low-grade prostate cancer and multidisciplinary discussions will likely continue. 

 

 

Sources: Oncol Lett, J Clin Oncol, J Nat Cancer Inst (Islami), J Nat Cancer Inst  (Welsh), Urology

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
DEC 14, 2021
Neuroscience
Research on Hunger Wins 2021 Eppendorf & Science Prize
DEC 14, 2021
Research on Hunger Wins 2021 Eppendorf & Science Prize
The American scientist Amber L. Alhadeff, Ph.D., Principal Investigator at the Monell Chemical Senses Center and the Uni ...
DEC 31, 2021
Cell & Molecular Biology
Cells Found to Release Super Small Bioactive Particles Called Supermeres
DEC 31, 2021
Cells Found to Release Super Small Bioactive Particles Called Supermeres
We know that cells are constantly secreting molecules that can have many different biological impacts; the term extracel ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
FEB 08, 2022
Health & Medicine
Meet the Terpene Humulene
FEB 08, 2022
Meet the Terpene Humulene
Although the more dominant and well-known terpenes like limonene and myrcene receive more research attention, several pa ...
APR 11, 2022
Health & Medicine
Upcoming Preventative Cancer Vaccine Trial Will Investigate Effects in Lynch Syndrome
APR 11, 2022
Upcoming Preventative Cancer Vaccine Trial Will Investigate Effects in Lynch Syndrome
Clinical trials are soon to be underway to examine the effectiveness of vaccines meant to prevent or delay cancer in hig ...
MAY 25, 2022
Cancer
TCGA: An Important Tool for Cancer Research
MAY 25, 2022
TCGA: An Important Tool for Cancer Research
In 2006, the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) began a cancer gen ...
Loading Comments...